Immunohistochemical observation showed that ACSS2 expression was high in metastatic prostate tumors, but relatively low in the surrounding normal tissues, and the expression level of ACSS2 in metastatic prostate tissues was higher than that in primary tumor tissues. The gene discussed is ACSS2; the disease is neoplasm.